G Marcucci1, L Cianferotti2, P Beck-Peccoz3, M Capezzone4, F Cetani5, A Colao6, M V Davì7, E degli Uberti8, S Del Prato9, R Elisei5, A Faggiano6, D Ferone10, C Foresta11, L Fugazzola3, E Ghigo12, G Giacchetti13, F Giorgino14, A Lenzi15, P Malandrino16, M Mannelli17, C Marcocci18, L Masi19, F Pacini20, G Opocher21,22, A Radicioni23, M Tonacchera5, R Vigneri24, M C Zatelli8, M L Brandi25. 1. Head, Bone Metablic Diseases Unit, Department of Surgery and Translational Medicine, University of Florence, Viale Pieraccini 6, 50139, Florence, Italy. gemma.marcucci@libero.it. 2. Head, Bone Metablic Diseases Unit, Department of Surgery and Translational Medicine, University of Florence, Viale Pieraccini 6, 50139, Florence, Italy. 3. Department of Clinical Sciences and Community Health, University of Milan and Endocrine Unit, Fondazione IRCCS Ca' Granda, Milan, Italy. 4. Section of Endocrinology and Metabolism, Department of Internal Medicine, Endocrinology and Metabolism and Biochemistry, University of Siena, Policlinico Santa Maria alle Scotte, Siena, Italy. 5. Unit of Endocrinology, Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy. 6. Dipartimento di Medicina Clinica e Chirurgia, Università Federico II di Napoli, Naples, Italy. 7. Section D, Department of Medicine, Clinic of Internal Medicine, University of Verona, Verona, Italy. 8. Section of Endocrinology, Department of Medical Sciences, University of Ferrara, Ferrara, Italy. 9. Section of Metabolic Diseases and Diabetes, Department of Endocrinology and Metabolism, University of Pisa, Pisa, Italy. 10. Endocrinology, Department of Internal Medicine and Medical Specialties and Center of Excellence for Biomedical Research, IRCCS AOU San Martino-IST, University of Genoa, Genoa, Italy. 11. Department of Medicine and Centre for Human Reproduction Pathology, University of Padova, Padua, Italy. 12. Division of Endocrinology, Diabetology and Metabolism Department of Medical Sciences, University Hospital Città Salute e Scienza, Turin, Italy. 13. Division of Endocrinology, Azienda Ospedaliero-Universitaria, Ospedali Riuniti Umberto I-GM Lancisi-G Salesi, Università Politecnica delle Marche, Ancona, Italy. 14. Section of Internal Medicine, Endocrinology, Andrology and Metabolic Diseases, Department of Emergency and Organ Transplantation, University of Bari Aldo Moro, Bari, Italy. 15. Chair of Endocrinology, Section Medical Pathophysiology, Food Science and Endocrinology, Department Exp. Medicine, Sapienza University of Rome, Policlinico Umberto I, Rome, Italy. 16. Endocrinology, Department of Clinical and Molecular Biomedicine, Garibaldi-Nesima Medical Center, University of Catania, Catania, Italy. 17. Endocrinology Unit, Department of Experimental and Clinical Biomedical Sciences, University of Florence, Florence, Italy. 18. Department of Endocrinology and Metabolism, University of Pisa, Pisa, Italy. 19. Department of Orthopedic, Metabolic Bone Diseases Unit AOUC-Careggi Hospital, Largo Palagi, 1, Florence, Italy. 20. Section of Endocrinology and Metabolism, University of Siena, Siena, Italy. 21. Familial Cancer Clinic and Oncoendocrinology, Veneto Institute of Oncology, IRCCS, Padua, Italy. 22. Department of Medicine DIMED, University of Padova, Padova, Italy. 23. Department of Experimental Medicine, Sapienza University of Rome, Rome, Italy. 24. Department of Clinical and Molecular Biomedicine, University of Catania, and Humanitas Catania Center of Oncology, Catania, Italy. 25. Head, Bone Metablic Diseases Unit, Department of Surgery and Translational Medicine, University of Florence, Viale Pieraccini 6, 50139, Florence, Italy. marialuisa.brandi@unifi.it.
Abstract
PURPOSE: Rare endocrine-metabolic diseases (REMD) represent an important area in the field of medicine and pharmacology. The rare diseases of interest to endocrinologists involve all fields of endocrinology, including rare diseases of the pituitary, thyroid and adrenal glands, paraganglia, ovary and testis, disorders of bone and mineral metabolism, energy and lipid metabolism, water metabolism, and syndromes with possible involvement of multiple endocrine glands, and neuroendocrine tumors. Taking advantage of the constitution of a study group on REMD within the Italian Society of Endocrinology, consisting of basic and clinical scientists, a document on the taxonomy of REMD has been produced. METHODS AND RESULTS: This document has been designed to include mainly REMD manifesting or persisting into adulthood. The taxonomy of REMD of the adult comprises a total of 166 main disorders, 338 including all variants and subtypes, described into 11 tables. CONCLUSIONS: This report provides a complete taxonomy to classify REMD of the adult. In the future, the creation of registries of rare endocrine diseases to collect data on cohorts of patients and the development of common and standardized diagnostic and therapeutic pathways for each rare endocrine disease is advisable. This will help planning and performing intervention studies in larger groups of patients to prove the efficacy, effectiveness, and safety of a specific treatment.
PURPOSE: Rare endocrine-metabolic diseases (REMD) represent an important area in the field of medicine and pharmacology. The rare diseases of interest to endocrinologists involve all fields of endocrinology, including rare diseases of the pituitary, thyroid and adrenal glands, paraganglia, ovary and testis, disorders of bone and mineral metabolism, energy and lipid metabolism, water metabolism, and syndromes with possible involvement of multiple endocrine glands, and neuroendocrine tumors. Taking advantage of the constitution of a study group on REMD within the Italian Society of Endocrinology, consisting of basic and clinical scientists, a document on the taxonomy of REMD has been produced. METHODS AND RESULTS: This document has been designed to include mainly REMD manifesting or persisting into adulthood. The taxonomy of REMD of the adult comprises a total of 166 main disorders, 338 including all variants and subtypes, described into 11 tables. CONCLUSIONS: This report provides a complete taxonomy to classify REMD of the adult. In the future, the creation of registries of rare endocrine diseases to collect data on cohorts of patients and the development of common and standardized diagnostic and therapeutic pathways for each rare endocrine disease is advisable. This will help planning and performing intervention studies in larger groups of patients to prove the efficacy, effectiveness, and safety of a specific treatment.
Authors: Aparna Balachandran; Eric P Tamm; Priya R Bhosale; Madhavi Patnana; Raghu Vikram; Jason B Fleming; Matthew H Katz; Chuslip Charnsangavej Journal: Abdom Imaging Date: 2013-04
Authors: Peter M Krawitz; Yoshiko Murakami; Jochen Hecht; Ulrike Krüger; Susan E Holder; Geert R Mortier; Barbara Delle Chiaie; Elfride De Baere; Miles D Thompson; Tony Roscioli; Szymon Kielbasa; Taroh Kinoshita; Stefan Mundlos; Peter N Robinson; Denise Horn Journal: Am J Hum Genet Date: 2012-06-07 Impact factor: 11.025
Authors: Murim Choi; Ute I Scholl; Peng Yue; Peyman Björklund; Bixiao Zhao; Carol Nelson-Williams; Weizhen Ji; Yoonsang Cho; Aniruddh Patel; Clara J Men; Elias Lolis; Max V Wisgerhof; David S Geller; Shrikant Mane; Per Hellman; Gunnar Westin; Göran Åkerström; Wenhui Wang; Tobias Carling; Richard P Lifton Journal: Science Date: 2011-02-11 Impact factor: 47.728
Authors: C Fava; M Montagnana; L Rosberg; P Burri; P Almgren; A Jönsson; P Wanby; G Lippi; P Minuz; L U Hulthèn; M Aurell; O Melander Journal: Hum Mol Genet Date: 2007-11-01 Impact factor: 6.150
Authors: M J Abramowicz; H M Targovnik; V Varela; P Cochaux; L Krawiec; M A Pisarev; F V Propato; G Juvenal; H A Chester; G Vassart Journal: J Clin Invest Date: 1992-10 Impact factor: 14.808